Search - tctmd.com

Displaying 141 - 160 of 393

Sort: Relevancy | Date

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

News Daily News

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

L.A. McKeown

July 01, 2015

Presentation

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

Presenter: Seiji Habara

June 30, 2015

News Daily News

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Yael L. Maxwell

June 26, 2015

Advertisement

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

QT Vascular wins CE Mark for drug-coated balloon

COMPARE:5 年时 EES 的疗效仍优于 PES

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

COMPARE: EES Maintains Advantage Over PES at 5 Years

QT Vascular Announces The Allowance Of Four New Patents

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content